213 Ces Urol 2024; 28(3): 205–213 PŘEHLEDOVÉ ČLÁNKY 42. Auprich M, Chun FKH, Ward JF, et al. Critical Assessment of Preoperative Urinary Prostate Can‑ cer Antigen 3 on the Accuracy of Prostate Cancer Staging. European Urology [Internet]. 1. leden 2011 [citován 1. srpen 2024]; 59(1): 96–105. Dostupné z: https://www.sciencedirect.com/science/article/pii/ S0302283810009620. 43. Vlaeminck-Guillem V, Ruffion A, André J, Devonec M, Paparel P. Urinary Prostate Cancer 3 Test: Toward the Age of Reason? Urology [Internet]. 1. únor 2010 [citován 22. září 2024]; 75(2): 447–53. Dostupné z: https://www.sciencedirect.com/science/article/pii/S0090429509005123. 44. Auprich M, Bjartell A, Chun FKH, et al. Contemporary Role of Prostate Cancer Antigen 3 in the Ma‑ nagement of Prostate Cancer. European Urology [Internet]. 1. listopad 2011 [citován 22. září 2024]; 60(5): 1045–54. Dostupné z: https://www.sciencedirect.com/science/article/pii/S0302283811008633. 45. Hessels D, Smit FP, Verhaegh GW, et al. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clinical Cancer Research. 2007; 13(17): 5103–8. 46. Schoenborn JR, Nelson P, Fang M. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification. Clin Cancer Res [Internet]. 1. srpen 2013 [citován 22. září 2024]; 19(15): 4058–66. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732571/. 47. Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer [Internet]. květen 2009 [citován 22. září 2024]; 100(10): 1603–7. Dostupné z: https://www.nature.com/articles/6605058. 48. Tomlins SA, Day JR, Lonigro RJ, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. European Urology [Internet]. 1. červenec 2016 [citován 22. září 2024]; 70(1): 45–53. Dostupné z: https://www.sciencedirect.com/science/article/pii/S0302283815003978. 49. Tosoian JJ, Singhal U, Davenport MS, et al. Urinary MyProstateScore (MPS) to Rule out Clinically‑ -Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need. Urology [Internet]. 1. červen 2022 [citován 22. září 2024]; 164: 184–90. Dostupné z: https://www. sciencedirect.com/science/article/pii/S0090429521011626. 50. Kohaar I, Chen Y, Banerjee S, et al. A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy. The Journal of Urology [Internet]. únor 2021 [citován 22. září 2024]; Dostupné z: https://www.auajournals.org/doi/10.1097/JU.0000000000001374. 51. Mlcochova H, Hezova R, Stanik M, Slaby O. Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urologic Oncology: Seminars and Original Investigations [Internet]. 1. leden 2014 [citován 22. září 2024]; 32(1): 41.e1-41.e9. Dostupné z: https://www.sciencedirect.com/science/article/pii/ S107814391300197X. 52. Ahumada-Tamayo S, Saavedra-Briones D, Cantellano-Orozco M, et al. MicroRNA determination in urine for prostate cancer detection in Mexican patients at the Hospital General Dr. Manuel Gea González. Rev Mex Urol [Internet]. 2011 [citován 22. září 2024]; 71(4): 213–7. Dostupné z: https://www.medigraphic. com/cgi- bin/new/resumenI.cgi?IDREVISTA=85 & IDARTICULO=31413 & IDPUBLICACION=3401. 53. Bryant RJ, Pawlowski T, Catto JWF, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer [Internet]. 14. únor 2012 [citován 1. srpen 2024]; 106(4): 768–74. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322952/. 54. Ferro M, Rocco B, Maggi M, et al. Beyond blood biomarkers: the role of SelectMDX in clinically signi‑ ficant prostate cancer identification. Expert Review of Molecular Diagnostics [Internet]. 2. prosinec 2023 [citován 22. září 2024]; 23(12): 1061–70. Dostupné z: https://doi.org/10.1080/14737159.2023.2277366. 55. Prostate Cancer – Uroweb [Internet]. [citován 22. září 2024]. Dostupné z: https://uroweb.org/guidelines/ prostate-cancer/chapter/diagnostic-evaluation.
RkJQdWJsaXNoZXIy NDA4Mjc=